
Intraocular Drug Delivery
CRC Press
1st Edition
Will be published approx. on 13. March 2006
Book
Hardback
384 pages
978-0-8247-2860-1 (ISBN)
Description
This reference studies the most recent advances in the development of ocular drug delivery systems. Covering methods to treat or prevent ocular inflammation, retinal vascular disease, retinal degeneration, and proliferative eye disease, this source covers breakthroughs in the management of endophthalmitis, uveitis, diabetic macular edema, and age-related macular degeneration.
More details
Language
English
Place of publication
Bosa Roca
United States
Publishing group
Taylor & Francis Inc
Target group
College/higher education
Ophthalmologists; pharmaceutical scientists, engineers, and chemists; pharmacologists; and researchers in these disciplines.
Dimensions
Height: 254 mm
Width: 178 mm
Weight
839 gr
ISBN-13
978-0-8247-2860-1 (9780824728601)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions

Glenn J. Jaffe | Paul Ashton | P. Andrew Pearson
Intraocular Drug Delivery
Book
11/2019
1st Edition
CRC Press
€76.74
Shipment within 15-20 days

Glenn J. Jaffe | Paul Ashton | P. Andrew Pearson
Intraocular Drug Delivery
E-Book
03/2006
CRC Press
€86.99
Available for download

Glenn J. Jaffe | Paul Ashton | P. Andrew Pearson
Intraocular Drug Delivery
E-Book
03/2006
1st Edition
CRC Press
€86.99
Available for download
Persons
Glenn J. Jaffe
Paul Ashton
P. Andrew Pearson
Paul Ashton
P. Andrew Pearson
Content
GENERAL. Retinal Drug Delivery. Blood Retinal Barrier. Neuroprotection. Regulatory Issues in Drug Delivery to the Eye. SPECIFIC DELIVERY SYSTEMS. Intravitreal Injection. Anti-angiogenic Agents. Intravitreal Antimicrobials. Pharmacologic Retinal Reattachment with INS37217 (Denufosol Tetrasodium), a Nucleotide P2Y2 Receptor Agonist. Cell Based Delivery Systems. Photodynamic Therapy. Thermal Sensitive Liposomes. Gene Therapy for Retinal Disease. Biodegradable Systems. Transscleral Drug Delivery to the Retina and Choroid. Nondegradable Intraocular Sustained Release Drug Delivery Devices. LOCAL DRUG DELIVERY APPROACH TO SPECIFIC CLINICAL DISEASES. Age-Related Macular Degeneration. Photodynamic Therapy Human Clinical Studies. Age-Related Macular Degeneration Drug Delivery. Intraocular Sustained Drug Delivery in Uveitis. Drug Delivery for Proliferative Vitreoretinopathy: Prevention and Treatment. Pharmacological Treatment in Diabetic Macular Edema. Retinal Vein Occlusion. Cytomegalovirus (CMV) Retinitis. Endophthalmitis